FGF14 and multiple system atrophy: Furthermore, a higher proportion of cases with dual pathology compared with FGF14-negative MSA cases presented with a mixed phenotype of parkinsonism and cerebellar ataxia (11.8%) compared with MSA patients without the FGF14 expansion (1.04%) (P = 0.05, adjusted P = 0.06).